ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 2343

$1.78M Total Retail Price of All Prescriptions

Rank: 12 out of 2343

469 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 29,191 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

65 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 1,095 1,065 1 6
SIMVASTATIN 1,044 970 2 1
METOPROLOL TARTRATE 973 943 3 7
AMLODIPINE BESYLATE 700 672 4 5
OMEPRAZOLE 633 617 5 4
ALENDRONATE SODIUM 570 564 6 28
LOSARTAN POTASSIUM 542 528 7 19
POTASSIUM CHLORIDE 509 481 8 18
DONEPEZIL HCL 486 485 9 21
ATENOLOL 461 460 10 12
PLAVIX 436 402 11 38
LISINOPRIL 421 419 12 3
CRESTOR 402 389 13 30
NEXIUM 395 390 14 33
ISOSORBIDE MONONITRATE ER 395 382 14 32
CLOPIDOGREL 394 370 16 26
MECLIZINE HCL 384 379 17 103
SINGULAIR 383 371 18 100
LEVOTHYROXINE SODIUM 365 349 19 2
FLUTICASONE PROPIONATE 358 356 20 46
METFORMIN HCL 344 344 21 9
TRAMADOL HCL 342 318 22 25
CILOSTAZOL 307 307 23 204
WARFARIN SODIUM 304 292 24 8
CLONIDINE HCL 303 303 25 70
LIDODERM 300 291 26 130
PRAVASTATIN SODIUM 296 283 27 15
AMLODIPINE BESYLATE-BENAZEPRIL 294 294 28 59
GLIPIZIDE XL 279 267 29 84
DIOVAN 267 254 30 23
ZOLPIDEM TARTRATE 260 241 31 24
SERTRALINE HCL 257 229 32 20
CREON 256 250 33 197
LOSARTAN-HYDROCHLOROTHIAZIDE 255 232 34 64
PROCTOZONE-HC 252 252 35 208
FEXOFENADINE HCL 241 238 36 240
LOVASTATIN 241 220 36 47
IBUPROFEN 235 217 38 75
ADVAIR DISKUS 227 219 39 34
MIRTAZAPINE 224 210 40 41
COMBIVENT 221 212 41 144
METOPROLOL SUCCINATE 218 207 42 14
TRICOR 215 204 43 96
ESCITALOPRAM OXALATE 205 201 44 55
MONTELUKAST SODIUM 204 197 45 181
SYNTHROID 201 201 46 40
ZETIA 201 201 46 52
ALLOPURINOL 198 188 48 31
VOLTAREN 193 192 49 175
JANUVIA 191 191 50 50
NAMENDA 190 190 51 36
GLIPIZIDE 189 185 52 56
ATORVASTATIN CALCIUM 185 185 53 10
GLIMEPIRIDE 181 181 54 45
GABAPENTIN 179 167 55 16
TAMSULOSIN HCL 173 167 56 29
DIOVAN HCT 169 169 57 63
NITROSTAT 164 154 58 164
CARVEDILOL 162 149 59 27
FAMOTIDINE 160 149 60 60
SOLARAZE 157 157 61 277
LACTULOSE 153 135 62 139
LIPITOR 152 152 63 78
NASONEX 151 148 64 209
AMMONIUM LACTATE 151 134 64 228
SINGLE USE SWAB 148 148 66 241
CHLORHEXIDINE GLUCONATE 146 146 67 219
TRIAMTERENE-HCTZ 146 136 67 57
LEVOCETIRIZINE DIHYDROCHLORIDE 144 144 69 223
RANITIDINE HCL 142 110 70 43
FINASTERIDE 140 137 71 80
HYDROCHLOROTHIAZIDE 136 135 72 11
IBANDRONATE SODIUM 133 128 73 288
TRAZODONE HCL 133 120 73 53
VYTORIN 129 129 75 185
AZITHROMYCIN 125 119 76 39
DILTIAZEM 24HR CD 125 125 76 83
KLOR-CON M20 125 124 76 44
DICYCLOMINE HCL 124 124 79 202
KETOCONAZOLE 123 123 80 232
LEXAPRO 120 111 81 178
FLOVENT HFA 117 117 82 213
BENICAR HCT 107 107 83 156
BONIVA 106 98 84 332
CITALOPRAM HBR 106 105 84 17
NIFEDIPINE ER 104 99 86 89
LIDOCAINE 103 103 87 258
LOVAZA 103 103 87 113
LANSOPRAZOLE 99 99 89 162
SPIRIVA 99 98 89 48
GLIPIZIDE ER 93 93 91 115
PANTOPRAZOLE SODIUM 92 86 92 22
SOTALOL 90 77 93 177
PRANDIN 87 87 94 140
KLOR-CON 10 87 86 94 134
PROAIR HFA 84 84 96 86
ACTOS 84 84 96 125
DIGOXIN 83 74 98 35
POLYETHYLENE GLYCOL 3350 82 82 99 54
HYDROCORTISONE 77 64 100 225
GLYBURIDE-METFORMIN HCL 76 76 R 101 154
METOLAZONE 76 69 101 173
DOXAZOSIN MESYLATE 74 74 103 98
PREDNISONE 71 65 104 37
ROPINIROLE HCL 70 70 105 124
AMIODARONE HCL 67 67 106 158
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 65 107 42
VESICARE 65 65 107 145
PROCHLORPERAZINE MALEATE 64 64 109 287
ENALAPRIL MALEATE 63 57 110 58
CIPROFLOXACIN HCL 63 56 110 72
ACTONEL 62 62 112 182
ALCOHOL PREP PADS 60 54 113 284
ACETAMINOPHEN-CODEINE 57 57 S3 114 112
MIDODRINE HCL 57 55 114 357
NIASPAN 57 57 114 141
METHIMAZOLE 56 56 117 324
BENICAR 55 55 118 93
JANUMET 54 54 119 191
TERAZOSIN HCL 52 52 120 143
HYDROCODONE-ACETAMINOPHEN 52 50 S3 120 13
BUMETANIDE 51 48 122 91
DILTIAZEM 24HR ER 51 51 122 76
HEPARIN SODIUM 51 38 122 198
NIFEDICAL XL 50 50 125 148
DEXILANT 50 50 125 184
KLOR-CON M10 50 50 125 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.